Some 170,000 Brits will benefit from the drug after the NHS spending watchdog recommended it for England for the first time.A migraine charity has called for “swift” access to the drug to ensure patients with the debilitating condition “can benefit from them as quickly as possible”.It works by blocking the receptor of a protein found in the sensory nerves of the head and neck, known as calcitonin gene-related peptide .
Ms Knight said patients with chronic migraines – that happen on more than 15 days of the month – “would welcome an oral treatment”. “We now need to ensure access is swift so that migraine patients can benefit from them as quickly as possible.” Rachael Millward, medical director at AbbVie UK, which makes the drug said: “AbbVie has an extensive history in migraine research and is committed to addressing the unmet needs of people living with this debilitating condition.”
Botox is a type of nerve toxin that paralyses muscles. It was discovered that those who had the cosmetic injections had fewer headaches.
United Kingdom Latest News, United Kingdom Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
'Very profitable' 170-year-old hotel in Scottish Highlands on saleA 170-YEAR-OLD hotel in the Highlands has been put on the market ...
Source: SunScotNational - 🏆 49. / 63 Read more »
Source: nottslive - 🏆 96. / 52 Read more »
Source: itvnews - 🏆 69. / 61 Read more »
Source: EchoWhatsOn - 🏆 74. / 59 Read more »
Source: SkyNews - 🏆 35. / 67 Read more »
Source: The Yorkshire Post - 🏆 39. / 66 Read more »